Idiopathic neutropenia of childhood is associated with Fas/FasL expression

Clinical Immunology

Volumn 129, Issue 3, 2008, Pages 438-447

  Nadeau, Kari C ^a   Callejas, Angel ^a   Wong, Wendy B ^a   Joh, Jae Won ^a   Cohen, Harvey J ^a   Jeng, Michael R ^a  

^a STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Apoptosis; ; Fas ligand; ; Fas; ; Idiopathic neutropenia; ; Neutropenia; ; Neutrophil disorder; ; Pediatric neutropenia;

Indexed keywords

FAS LIGAND;

ADOLESCENT; APOPTOSIS; ARTICLE; BIOCHEMISTRY; BLOOD LEVEL; CHILD; CHILDHOOD; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE SEVERITY; HUMAN; IMMUNOCOMPETENT CELL; NEUTROPENIA; NEUTROPHIL; PRIORITY JOURNAL; PROTEIN EXPRESSION;

ANTIGENS, CD95; APOPTOSIS; CHILD; CHILD, PRESCHOOL; CYTOKINES; FAS LIGAND PROTEIN; FLOW CYTOMETRY; HL-60 CELLS; HUMANS; IMMUNOGLOBULIN G; INFANT; NEUTROPENIA; NEUTROPHILS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION;

EID: 55249085092     PISSN: 15216616     EISSN: 15217035     Source Type: Journal    
DOI: 10.1016/j.clim.2008.08.006     Document Type: Article

References (35)

1. Sera Y., Kawaguchi J., Nakamura K., Sato T., Habara M., Okada S., Ishikawa N., Kojima S., Katoh O., and Kobayashi M. A comparison of defective granulopoiesis in childhood cyclic neutropenia and in severe congenital neutropenia. Haematologica 90 (2005) 1032-1041
2. Carlsson G., Melin M., Dahl N., et al. Kostmann syndrome or infantile genetic agranulocytosis, part two: Understanding the underlying genetic defects in severe congenital neutropenia. Acta Paediatr. 96 (2007) 813-819
3. Donini M., Fontana S., Savoldi G., et al. G-CSF treatment of severe congenital neutropenia reverses neutropenia but does not correct the underlying functional deficiency of the neutrophil in defending against microorganisms. Blood 109 (2007) 4716-4723
4. Capsoni F., Sarzi-Puttini P., and Zanella A. Primary and secondary autoimmune neutropenia. Arthritis Res. Ther. 7 (2005) 208-214
5. Kuijpers T.W. Clinical symptoms and neutropenia: the balance of neutrophil development, functional activity, and cell death. Eur. J. Pediatr. 161 Suppl 1 (2002) S75-S82
6. Wright D.G., Meierovics A.I., and Foxley J.M. Assessing the delivery of neutrophils to tissues in neutropenia. Blood 67 (1986) 1023-1030
7. Cham B., Bonilla M.A., and Winkelstein J. Neutropenia associated with primary immunodeficiency syndromes. Semin. Hematol. 39 (2002) 107-112
8. Bernini J.C. Diagnosis and management of chronic neutropenia during childhood. Pediatr. Clin. North Am. 43 (1996) 773-792
9. Weetman R.M., and Boxer L.A. Childhood neutropenia. Pediatr. Clin. North Am. 27 (1980) 361-376
10. Carlsson G., Aprikyan A.A., Ericson K.G., et al. Neutrophil elastase and granulocyte colony-stimulating factor receptor mutation analyses and leukemia evolution in severe congenital neutropenia patients belonging to the original Kostmann family in northern Sweden. Haematologica 91 (2006) 589-595
11. Grenda D.S., Murakami M., Ghatak J., Xia J., Boxer L.A., Dale D., Dinauer M.C., and Link D.C. Mutations of the ELA2 gene found in patients with severe congenital neutropenia induce the unfolded protein response and cellular apoptosis. Blood 110 (2007) 4179-4187
12. Lekstrom-Himes J.A., and Gallin J.I. Immunodeficiency diseases caused by defects in phagocytes. N. Engl. J. Med. 343 (2000) 1703-1714
13. Bruin M.C., von dem Borne A.E., Tamminga R.Y., Kleijer M., Buddelmeijer L., and de Haas M. Neutrophil antibody specificity in different types of childhood autoimmune neutropenia. Blood 94 (1999) 1797-1802
14. Bux J., Behrens G., Jaeger G., and Welte K. Diagnosis and clinical course of autoimmune neutropenia in infancy: analysis of 240 cases. Blood 91 (1998) 181-186
15. Kobayashi M., Nakamura K., Kawaguchi H., et al. Significance of the detection of antineutrophil antibodies in children with chronic neutropenia. Blood 99 (2002) 3468-3471
16. Morgan E., Varro R., Sepulveda H., et al. Cytometric bead array: a multiplexed assay platform with applications in various areas of biology. Clin. Immunol. 110 (2004) 252-266
17. Liu J., Wei S., Lamy T., Djeu J., and Loughran T. Chronic Neutropenia mediated by Fas ligand. Blood 95 (2000) 3219-3222
18. Grenda D., Murakami M., Ghatak J., Xia J., Boxer L., Dale D., Dinauer M., and Link D. Mutations of the Ela2 gene found in patients with severe congenital neutropenia induce the unfolded protein response and cellular apoptosis. Blood (2007) E publication. August 27, 2007
19. Kuijpers T.W. Clinical symptoms and neutropenia: the balance of neutrophil development, functional activity, and cell death. Eur. J. Pediatr. 161 Suppl 1 (2002) S75-S82
20. Wright D.G., Meierovics A.I., and Foxley J.M. Assessing the delivery of neutrophils to tissues in neutropenia. Blood 67 (1986) 1023-1030
21. Cham B., Bonilla M.A., and Winkelstein J. Neutropenia associated with primary immunodeficiency syndromes. Semin. Hematol. 39 (2002) 107-112
22. Weetman R.M., and Boxer L.A. Childhood neutropenia. Pediatr. Clin. North Am. 27 (1980) 361-376
23. Lamy T., Liu J., Landowski T.H., and Loughran T.P. Dysregulation of CD95/CD95 ligand-apoptotic pathway in CD3(+) large granular lymphocyte leukemia. Blood 92 (1998) 4771-4777
24. Jethwaney D., Islam M., Leidal K., and Gibson B. Proteomic analysis of plasma membrane and secretory vesicles of human neutrophils. Proteome Science 10 (2007) 5-12
25. Vargo-Gogola T., Crawford H.C., Fingleton B., and Matrisian L.M. Identification of novel MMP-7 cleavage sites in murine and human Fas ligand. Arch. Biochem. Biophys. 408 (2002) 155-161
26. Vanden Berghe T., Van Loo G., and Vandenabeele P. Differential Signaling to apoptotic and necrotic cell death by Fas-associated death domain protein FADD (in Jurkat cells). J. Biol. Chem. 279 (2004) 7925-7933
27. Dorne J., Sapala K., and Zunino S.J. IFN-γ increases the expression of CD95 in leukemic cells. Cytokine 18 (2002) 98-107
28. Urbaniak-Kujda D., Wolowiec D., and Kuliczkowski K. Expression of Fas receptor and sFasL is acute leukemia. Pol. Arch. Med. Wewn. 108 (2002) 873-878
29. Dupont P.J., and Warrens A.N. FasL exerts its pro-inflammatory effects via neutrophil recruitment but not activation. Immunology 120 (2007) 133-139
30. Papadaki H.A., Eliopoulos A.G., Kosteas T., Gemetzi C., Damianaki A., Koutala H., Bux J., and Eliopoulos G.D. Impaired granulocytopoiesis in patients with chronic idiopathic neutropenia is associated with increased apoptosis of bone marrow myeloid progenitor cells. Blood 101 (2003) 2561-2600
31. Koumaki V., Papadaki H.A., Stefanaki K., Vrentzos G., and Eliopoulos G.D. Increased cell apoptosis in bone marrow trephine biopsies and immunomagnetically isolated myeloid progenitor cells in patients with chronic idiopathic neutropenia. Ann. Hematol. 82 (2003) 641-645
32. Papadaki H.A., and Eliopoulos G.D. The role of apoptosis in the pathophysiology of chronic neutropenias associated with bone marrow failure. Cell Cycle 2 (2003) 447-451
33. Lee C., Raz R., Takeshita R., DePinho R., and Levy D. STAT3 is a negative regulatory of granulopoiesis but is not required for GCSF-dependent differentiation. Immunity 17 (2003) 63-72
34. Pan H., Hong F., Radaeva S., and Gao B. Gene therapy of IL-22 protects from Fas L induced injury via activation of STAT3. Cell Mol. Immunol. 22 (2004) 43-49
35. Ivanov V.N., Levy D., Horvath C.M., and Ronai Z. Cooperation between STAT3 and cJun suppresses Fas transcription. Mol. Cell 51 (2001) 517-528